It's you who is always on the offensive, making negative claims about MSB.
Clearly this is an emerging bluechip. If it was already a bluechip with projected income streams the SP would be far higher.
It is disingenuous to carry on as if we should be able to predict income streams exactly.
If people are prepared to research this company, instead of relying on what passes for analysis in HC, they will see the opportunities.
You get rich by making careful selections and having a lot of patience; this is conviction investing and contra investing. Many will try to shake your convictions and you should ask yourself why someone would do just that so persistently especially if they don't hold the stock.
Do they really believe MSB is cash strapped and riddled with risk? If they did, surely they'd move on to better targets for their energy.
Also attack is the best form of defence, the continual assaults on the stock, and on some of us who take the trouble to defend at times raise plenty of unintended questions.
Again: look back at the timeframe for 2015, and the logic of the agreement with Teva and the fact that MSB and Teva are concentrating on getting some applications to market more quickly.
Once that happens there will be a halo effect on the other applications and we will be looking at an entirely different scenario with the SP.
IMO time is running out for anyone seeking to accumulate so cheaply. Therefore IMO much more effort and pressure being exerted with the supposed analyses about cash flow, income streams etc and urgency is being created. It's not the company's urgency.
What is the cost benefit analysis for time expended on stock not held? At some point a conclusion is reached the stock is either worth accumulating or not worth accumulating. But we have continual assaults which go on for months on end, and no conclusions. And again we have supposed cash flow and income stream urgency? Really?
Remember when you sign on, there is a disclaimer and a warning. DYOR and don't rely on what individuals in here might be telling you.
MSB Price at posting:
$4.24 Sentiment: Buy Disclosure: Held
(20min delay)